Volume 1, Issue 1 (11-2017)                   GMJ Medicine 2017, 1(1): 21-26 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sedighi S, Nasiri B, Alipoor R, Moradi-kor N. Modulation of 6-gingerolin Antidepressant-like Effects: An Investigation of Serotonergic System in Mice Model . GMJ Medicine. 2017; 1 (1) :21-26
URL: http://gmjpress.de/article-1-32-en.html
1- MD, Islamic Azad University, Tehran Medical Branch, Tehran, Iran
2- MD, Lorestan University of Medical Sciences, Khorramabad, Iran
3- Student Research Committee, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
4- Center of Advanced Scientific Research and Publications, Haslemere, Surrey, London, United Kingdom
Full-Text [PDF 828 kb]   (106 Downloads)     |   Abstract (HTML)  (334 Views)
Full-Text:   (128 Views)
Major depressive disorder has been known a complex psychiatric disorder with unknown cause which will involve up to 20% of the individuals during their lifetime [1] and it causes disability in people [2]. It has been known to have some symptoms including adverse effects on mood, interest, feeling, hope, appetite, sleep, performance and social relationships [3]. Oxidative stress is result of excessive formation offree radicals and it is also attributed to antioxidant defense mechanism which maintains the cells removing free radicals [4]. Oxidative stress is involved in some psychiatric disorders [5, 6] which could be attributed to excessive oxygen consumption and lipid-rich compounds of the brain [7, 8]. Studies have related depression with faulted antioxidative enzyme activities [9-11]. The faulted antioxidant system could reduce the protection against reactive oxygen species (ROS) [9]. Elevated ROS in depression has been related with increased levels of malondialdehyde and arachidonic acid [9]. It has been reported increased oxidative stress in the rats exposed to stress [12]. These evidences suggest therapeutic activity of antioxidant compounds for treatment of depression [13]. 6-Gingerol is known as one phenolic compound which is found in some plants in Zingiberaceae family including ginger, cardamom and grain of paradise. It has been known to have some properties such as cognitive enhancer [14], anti-apoptotic [15], antioxidant and anti-inflammatory [16]. It has been reported effect of ginger on gastric similar to metoclopramide, a 5-HT4 receptor agonist with antagonist properties at 5-HT3 receptors through a selective 5-HT3 receptor antagonist [17, 18]. This study was thus conducted to evaluate the antidepressant-like activity of gingerol in mice model.    
Materials and Methods

Gingerol powder and DMSO (Dimethyl sulphoxide) were purchased from Chromadex (Santa Ana, CA, USA) and Scharlo (Spain), respectively.
A number of 24 male NMRI mice, 4 wk of age with 28±2 g weight, were purchased from Pasteur Institute (Tehran, Iran). Those were maintained under lighting program (12h L: 12h D). Animals had free access to water and feed. Commercial feed was purchased from Razi Vaccine and Serum Research Institute (Karaj-Iran). All the used procedures were approved by National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978).
Acute toxicity test
Previous procedures [19] were used to evaluate the acute toxicity test. Following 24 h food restriction, 24 mice were divided into 4 groups and intrapritoeanally received 200, 400, 800 and 1200 mg/kg gingerol dissolved in DMSO. Following treatment, animals were considered for some toxicity signs and behavioral symptoms including locomotor activity, changes in physical appearancerespiratory distress, coma, and mortality for 72 h. This action was conducted for 10 days and to be healthiness and mortality were recorded [20]. We did not observe any mortality and only dizziness was observed in levels of 800-1200 mg/kg. Thus, we selected levels of 100and 300 mg/kg for future studies.
Tail suspension test
Tail suspension test was conducted as reported by previous studies and total period of immobility was considered as reported by previous studies [21]. Animals were divided into 4 groups with 6 mice and treated by follow protocol: 1) Vehicle group= mice intra pritoeanally received normal saline (10 ml/kg). 2 and 3) G-100, and G-200, mice intrapritoeanally received 100 and 200 mg/kg gingerol, and 4) Fluoxetine= mice intra pritoeanally received 20 mg/kgfluoxetine. To evaluate the tail suspension test, total period of immobility time was registered by using a chronometer. Decreased immobility time was considered as a criteria for antidepressant activity [22, 23].
Evaluation of serotonergic system in the antidepressant-like effect of gingerol
To investigate the serotonergic system, pre-treatment with PCPA, blocker of 5HT synthesis, was conducted (once/d for 3consecutive days). Since the best responses were observed in 300 mg/kg gingerol, same dose was used in future trials. Following pre-treatment with PCPA, animals were treated with 300 mg/kg gingerol, 15 min after last administration of PCPA. Animals were submitted to tail suspension test after administration of gingerol [24]. To evaluate the involvement of 5HT1 receptor, mice were pre-treated withWAY100135 (10 mg/kg), treated with 300 mg/kg gingerol60 min after pre-treatment and exposed to tail suspension test after administration of gingerol [25]. To assess the involvement the 5HT2 receptor, animals were pre-treated with ketanserin and cyproheptadine, treated with 300 mg/kg gingerol 60 min after pre-treatment and finally submitted to ail suspension test [26, 27].
Open field test (OFT)
To evaluate the psychomotor stimulant activity, OFT was conducted as reported by others [28]. Each mouse was grouped in Plexiglas boxes (40×60×50 cm). All the crossings and rearing were registered. We considered crossing as locomotors activity and rearing as exploratory behavior. 
Statistical analysis
The data were reported as mean± standard deviation (Mean±SD) and analyzed by one-way analysis of variance (ANOVA) and Two-was analysis. Tukey post-hoc test was used to comparethe groups. A level ofP<0.05 was considered assignificant. The figures were illustrated by Prism, version 7 (GraphPad Software, Inc., San Diego, CA, USA).
Our findings for tail suspension test are shown in Figure 1. Results showed that administration of gingerol could significantly decrease immobility time (P<0.05). Immobility was decreased with increasing dose, so that lowest immobility time was observed in mice administrated with 300 mg gingerol. There was no significant difference between fluoextine with 300 mg gingerol.  

Figure 1. Effect of intra-pritoeanal administration of 6-gingerol in tail suspension test. The data are shown in mean±SD. Superscripts (a-c) show significant difference among groups. The data were analyzed by one-way ANOVA. 

The data for pretreatment of mice with pCPA (preventer of serotonin synthesis), WAY100135 (receptor antagonist), ketanserin (5HT2A receptor antagonist), and cyproheptadine (5HT2 receptor antagonist) in antidepressant-like effect induced by gingerol in tail suspension test are Figure 2. As results show pretreatments significantly prevented the antidepressant-like effect induced by the gingerol.

Figure 2. Pretreatment of mice with pCPA (preventorof serotonin synthesis), WAY100135 (receptor antagonist), ketanserin (5HT2A receptor antagonist), and cyproheptadine (5HT2 receptor antagonist) in antidepressant-like effect induced by gingerolin tail suspension test. Superscripts (a-c) show significant difference among groups. The data were analyzed by two-way ANOVA.
Our findings for OFT are shown in Figure 3. Results showed that number of OFT was not different among different groups (P>0.05).

Figure 3. Effect of gingerol in OFT in mice.The data are shown in mean±SD. Superscripts (a-c) show significant difference among groups. The data were analyzed by one-way ANOVA. 

The present results showed that use of the gingerol as an antidepressant agent could express antidepressant-like activity in tail suspension test in mice. Tail suspension test has been known as one behavioral model for detection of antidepressant activity. In the model, decreased immobility time were considered as an indicator for antidepressant-like action [29]. Tail suspension test has been used to evaluate the depressive-like behaviors in mice because it could imitate helpless behaviors that frequently seen in patients with depression [30].We did not observe differences for immobility time. Increased locomotor activity could be considered as false response. We could not find in the published literature any study to show antidepressant activity of gingerol. With regards to our findings, it showed antidepressant-like effect of gingerol by modulation in serotonin system. The data for acute mechanism of antidepressant drugs caused to be considered by monoaminergic system [31]. The monoamine pathways such as serotonergic transmission have been known as target site for antidepressant drugs [32]. It has been accepted more or less that most of the drugs administrated for treatment of depression is involved in monoamine neurotransmitters [33]. However, pre-treatment with pCPA (preventer of serotonin synthesis), WAY100135 (receptor antagonist), ketanserin (5HT2A receptor antagonist), and cyproheptadine (5HT2 receptor antagonist) could prevent decreased immobility period induced by gingerol. It means that serotonergic system is involved in the antidepressant effects of gingerol in the tail suspension test in the mice. Previous studies have shown the role of 5HT as one neurotransmitter in depression, because it is involved in some symptoms of major depression [34]. Other reason is that 5HT1A receptors clearly modulate in the clinical effect of antidepressants [35] due to its position in the soma and dendrites of 5HT neurons in the dorsal raphe which inhibit to release 5HT [36]. Previous studies have also reported that ketanserin could prevent antidepressant activity in some herbal medicines in the tail suspension test in the animal model [33, 37]. It has been known tryptophan as substrate for synthesis of serotonin. We believed that gingerol could partly prevent oxidation of tryptophandue to its antioxidant properties. Unfortunately, we could not find any published study in the literature which showing effects of gingerol on serotonergic system.
In summary, it could be stated that gingerol could be involved in serotonergic system and show antidepressant-like effect. We suggest touse the gingerol for treatment of depression as a novel agent in commercial preparation and prescribed as a drug for therapeutic reasons.

Ethical Considerations

Compliance with ethical guidelines
There was no ethical consideration to be considered in this research.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Authors' contributions
All authors contributed toward data analysis, drafting and revising the paper and agreed to be responsible for all the aspects of this work.

Conflict of interest
The authors declared no conflict of interest.


[1] Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity SurveyReplication. Arch Gen Psychiatry. 2005;62(6):617-27. [DOI:10.1001/archpsyc.62.6.617] [PMCID]

[2] Kessler RC, Bromet EJ. The epidemiology of depression across cultures.Annu Rev Public Health. 2013;34:119. [DOI:10.1146/annurev-publhealth-031912-114409] [PMID] [PMCID] 

[3] Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. AnnuGen Psychiatry. 2017; 16:14. [DOI:10.1186/s12991-017-0138-2] [PMID] [PMCID] 

[4] McCord JM. Human disease, free radicals, and the oxidant/antioxidant balance. ClinBiochem. 1993; 26: 351-357. [DOI:10.1016/0009-9120(93)90111-I]
[5] Bouayed J, Rammal H, Soulimani R. Oxidative stress andanxiety relationship and cellular pathways. Oxidative MedCell Longevity. 2009;2:63-67.[DOI:10.4161/oxim.2.2.7944] 

[6] Hovatta I, Juhila J, Donner J. Oxidative stress in anxietyand comorbid disorders. Neurosci Res. 2010; 68: 261-275. [DOI:10.1016/j.neures.2010.08.007] [PMID]

[7] Halliwell B. Oxidative stress and neurodegeneration: whereare we now? J Neurochem.2006; 97: 1634-1658. [DOI:10.1111/j.1471-4159.2006.03907.x][PMID]

[8] Berk M, Ng F,Dean O, Dodd S, Bush AI. Glutathione: anovel treatment target in psychiatry.Trend PharmacolSci. 2008; 29: 346-351. [DOI:10.1016/j.tips.2008.05.001] [PMID] 

[9] Maes M, Galecki P, Chang YS, Berk M.A reviewon the oxidative and nitrosative stress (O&NS) pathwaysin major depression and their possible contribution to the(neuro)degenerative processes in that illness.ProgrNeuro-PsychopharmacolBiol Psychiatry. 2011;276-692. [DOI:10.1016/j.pnpbp.2010.05.004] [PMID]

[10] Scapagnini G, Davinelli S, Drago F, de Lorenzo A, Oriani G. Antioxidants as antidepressants: fact or fiction? CNSDrugs. 2012; 26:477-490. [DOI:10.2165/11633190-000000000-00000] [PMID] 

[11] Erel O. A novel automated direct measurement method fortotal antioxidant capacity using a new generation, more stableABTS radical cation.ClinBiochem.2004; 34: 277-285. [DOI:10.1016/j.clin-biochem.2003.11.015] [PMID]

[12] Lucca G, Comim CM, Valvassori SS. Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. JPsychiatric Res. 2009;9: 864-869. [DOI:10.1016/j.jpsychires.2008.11.002] [PMID]

[13] Scapagnini G, Davinelli S, Drago F, de Lorenzo A, Oriani G. Antioxidants as antidepressants: fact or fiction? CNS Drug. 2012; 26: 477-490. [DOI:10.2165/11633190-000000000-00000] [PMID] 

[14] Saenghong N. Zingiberofficinale improves cognitive function of the middle-aged healthy women. Evid. Based Complement. Alternat. Med. 2012: 2011;13-23. [DOI:10.1155/2012/383062] [PMID] [PMCID]

[15] Seo HB, Kwon TD, Song YJ. The effect of ginger extract ingestion and swimming exercise on insulin resistance and skeletalmuscle antioxidant capacity and apoptosis in hyperglycemic rats fed a high-fructose diet. J ExercNutrBiochem. 2011; 15:41-48. [DOI:10.5717/jenb.2011.15.1.41]

[16] Surh, YJ. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat ResFundamMolMechMutag. 1999; 428: 305-327. [DOI:10.1016/S1383-5742(99)00057-5]

[17] Yamahara J, Huang Q, Li Y, Xu L, Fujimura H. Gastrointestinal motility enhancing effect of ginger and its active constituents.  Chem Pharm Bull. 1990; 38: 430-431. [DOI:10.1248/cpb.38.430] [PMID]

[18] Sharma SS, Gupta YK. Reversal of cisplatin-induced delay in gastric emptying in rats by ginger (Zingiberofficinale).  J Ethnopharmacol. 1998; 62: 49-55. [DOI:10.1016/S0378-8741(98)00053-1] 

[19] Lorke D. A new approach to practical acute toxicity. Arch Toxicol. 1983; 53:275-289. [DOI:10.1007/BF01234480] 

[20] OECD/OCDE 423. OECD web. Consulted 22 May 2009. http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OECD GL423.pdf.

[21] Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol.1985; 85:367-370. [DOI:10.1007/BF00428203] 

[22] Jesse CR, Wilhelm EA, Bortolatto CF, Nogueira CW. Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice. PharmacolBiochemBehav. 2010; 95:344-350. [DOI:10.1016/j.pbb.2010.02.011] [PMID]

[23] Voiculescu SE, Rosca AE, Zeca V, Zagrean L, Zagrean AM. Impact of maternal melatonin suppression on forced swim and tail suspension behavioral despair tests in adult offspring. J Med Life.2015; 8:202-206. 

[24] Harkin A, Connor T, Walsh M, St John N, Kelly J. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacol. 2003; 44:616-623. [DOI:10.1016/S0028-3908(03)00030-3]

[25] Tanyeri P, Buyukokuroglu ME, Mutlu O, Ulak G, Akar FY, Celikyurt IK, et al. Involvement of serotonin receptor subtypes in the antidepressant-like effect of beta receptor agonist Amibegron (SR 58611A): an experimental study. PharmacolBiochemyBehav. 2013; 105:12-16. [DOI:10.1016/j.pbb.2013.01.010] [PMID]

[26] Gu L, Liu YJ, Wang YB, Yi LT. Role for monoaminergic systems in the antidepressant-like effect of ethanol extracts from Hemerocalliscitrina. J Ethnopharmacol. 2012; 139:780-787. [DOI:10.1016/j.jep.2011.11.059] [PMID]

[27] Zheng M, Li Y, Shi D, Liu C, Zhao J. Antidepressant-like effects of flavonoids extracted from Apocynumvenetum leaves in mice: the involvement of monoaminergic system in mice. Afr J Pharm Pharmacol. 2014; 8:765-774. [DOI:10.5897/AJPP12.641]

[28] Brown RE, Corey SC. Moore AK. Differences in Measures of Exploration and Fear in MHC-Congenic C57BL/6J and B6-H-2K Mice. Behav Gen. 1999; 29:263. [DOI:10.1023/A:1021694307672]

[29] Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol. 1985; 85:367-370. [DOI:10.1007/BF00428203] 

[30] Porsolt RD, Bertin A,Jalfre M. Behavioural despair” in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol. 1978; 51:291-294. [DOI:10.1016/0014-2999(78)90414-4] 

[31] Berton O,Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nature Rev Neurosci. 2006; 7:137-151. [DOI:10.1038/nrn1846] [PMID]

[32] Xu Y, Wang Z, You W, Zhang X, Li S, Barish PA, Vernon MM, Du X, Li G, Pan J, Ogle WO. Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system. EurNeuropsychopharmacol. 2010; 20:405-413. [DOI:10.1016/j.euroneuro.2010.02.013] [PMID]

[33] Risch SC, Nemeroff CB. Neurochemical alterations of serotonergic neuronal systems in depression. J Clin Psychiatry.1992; 53:3-7.

[34] Haider S, Khaliq S, Haleem DJ. Enhanced serotonergic neurotransmission in the hippocampus following tryptophan administration improves learning acquisition and memory consolidation in rats. Pharmacol Rep. 2007; 59:53.

[35] Celada P, Puig MV, Amargós-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT 1A and 5-HT 2A receptors in depression. Psychiatry Neurosci. 2004; 29:252.

[36] Shrestha S, Hirvonen J, Hines CS, Henter ID, Svenningsson P, Pike VW, et al. Serotonin-1A receptors in major depression quantified using PET: controversies, confounds, and recommendations. Neuroimage. 2012; 59:3243-3251. [DOI:10.1016/j.neuroim-age.2011.11.029] [PMID] [PMCID]

[37] Machado DG, Bettio LE, Cunha MP, Capra JC, Dalmarco JB, Pizzolatti MG, et al. Antidepressant-like effect of the extract of Rosmarinusofficinalis in mice: involvement of the monoaminergic system. ProgNeuro-PsychopharmacolBiolPsychiatr. 2009; 33:642-650. [DOI:10.1016/j.pnpbp.2009.03.004] [PMID] 
Type of Study: Original Article | Subject: Physiology
Received: 2017/09/28 | Accepted: 2017/10/30 | Published: 2017/11/25

Add your comments about this article : Your username or Email:

© 2019 All Rights Reserved | GMJ Medicine